In reference to the finalization of the draft Administrative Order entitled “Implementing Guidelines on the Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services Repealing Administrative Order No. 50s. 2001, entitled, “Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs”” and its Amendments, the FDA is hereby inviting its stakeholders to join the Public Consultation to be held on 29 and 30 November 2023, at venue within Manila. Two (2) participant per association shall be allowed in the Public Consultation.
The registration to the Public Consultation is accessible through this link:
Stakeholders of processed food products, ingredients and raw materials under the Center for Food Regulation Research
https://forms.office.com/r/Pvs0NiieH7
Stakeholders of drug products under the Center for Drug Regulation and Research
https://forms.office.com/r/8QYnnnaALh
Stakeholders of medical device, health-related device and radiation facilities under the Center for Device Regulation, Radiation Health, and Research
https://forms.office.com/r/GsSW1JPgR9
Stakeholders of cosmetics, toys and childcare articles, household/urban hazardous substances, household/urban pesticides under the Center for Cosmetics and Household/Urban Hazardous Substances Regulation and Research
https://forms.office.com/r/6tqFBDgw5E
Limited slots are available, as such, registration is on a first-come, first-served basis.
A confirmation email shall be sent to the nominated participant through the registered email address, to be presented during the registration on the day of the Public Consultation.
Further, provided herewith is the copy of the draft Administrative Order for reference.
Thank you very much.